Michele Moschetta, MD PhD
机构: Executive Director, Early Clinical Development Oncology, AstraZeneca
每年引用次数
引用次数
引用: 6,690
H-指数: 52
I10-指数 : 86
出版物: 172
Class I PI3K Isoforms Exert a Differential Role On Survival and Cell Trafficking In Multiple Myeloma
Ilyas Sahin , Feda Azab , Michele Moschetta , Yuji Mishima
Blood 122 ( 21) 3159 -3159
2013
Targeting the bone marrow microenvironment in multiple myeloma
Yawara Kawano , Michele Moschetta , Salomon Manier , Siobhan Glavey
Immunological Reviews 263 ( 1) 160 -172
180
2015
Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?
Michele Moschetta , Stergios Boussios , Elie Rassy , Eleftherios P. Samartzis
Annals of Translational Medicine 8 ( 24) 1710 -1710
26
2020
Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets—a narrative review
Eleftherios P. Samartzis , S. Intidhar Labidi-Galy , Michele Moschetta , Mario Uccello
Annals of Translational Medicine 8 ( 24) 1712 -1712
3
2020
Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer.
Michele Moschetta , Gabriel Mak , Joana Hauser , Catriona Davies
Experimental hematology & oncology 6 ( 1) 1 -5
4
2017
Deciphering Clonal Evolution and Dissemination of Multiple Myeloma Cells In Vivo
Yujia Shen , Yuji Mishima , Jiantao Shi , Michele Moschetta
Blood 132 55 -55
2018
HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target.
Roberto Ria , Ivana Catacchio , Simona Berardi , Annunziata De Luisi
Clinical Cancer Research 20 ( 4) 847 -858
31
2014
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target
Arianna Ferrucci , Michele Moschetta , Maria Antonia Frassanito , Simona Berardi
Clinical Cancer Research 20 ( 22) 5796 -5807
39
2014
Abstract A106: Mechanisms underlying extra-medullary myeloma development
Yuji Mishima , Aldo Roccaro , Michele Moschetta , Yasuhito Terui
Molecular Cancer Therapeutics 14
2015
Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
Stergios Boussios , Charlotte Abson , Michele Moschetta , Elie Rassy
Drugs in R & D 20 ( 2) 55 -73
79
2020
Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspects
Stergios Boussios , Michele Moschetta , George Zarkavelis , Alexandra Papadaki
Critical Reviews in Oncology Hematology 120 43 -51
13
2017
Dual Conditional Loss of BLIMP-1 and p53 in B-Cells Drives B-Cell Lymphomagenesis
Antonio Sacco , Yawara Kawano , Michele Moschetta , Jihye Park
Blood 128 ( 22) 4169 -4169
2016
Exosomes in Tumor Angiogenesis.
Karma Z. Salem , Michele Moschetta , Antonio Sacco , Luisa Imberti
Methods of Molecular Biology 1464 25 -34
41
2016
Multiple Myeloma Macrophages: Pivotal Players in the Tumor Microenvironment
Simona Berardi , Roberto Ria , Antonia Reale , Annunziata De Luisi
Journal of Oncology 2013 183602 -183602
33
2013
Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade
Michele Moschetta , Mario Uccello , Benjamin Kasenda , Gabriel Mak
BioMed Research International 2017 1506824 -1506824
47
2017
Platelets Enhance Multiple Myeloma Progression via IL-1β Upregulation.
Satoshi Takagi , Shokichi Tsukamoto , Jihye Park , Kelly E. Johnson
Clinical Cancer Research 24 ( 10) 2430 -2439
15
2018
A Randomized, Open-label, Presurgical, Window-of-Opportunity Study Comparing the Pharmacodynamic Effects of the Novel Oral SERD AZD9496 with Fulvestrant in Patients with Newly Diagnosed ER+ HER2- Primary Breast Cancer.
John FR Robertson , Abigail Evans , Stephan Henschen , Cliona C Kirwan
Clinical Cancer Research 26 ( 16) 4242 -4249
4
2020
Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination With Fulvestrant in Patients With AKT1 E17K-Mutant, ER-Positive Metastatic Breast Cancer.
Lillian M. Smyth , Kenji Tamura , Mafalda Oliveira , Eva M. Ciruelos
Clinical Cancer Research 26 ( 15) 3947 -3957
10
2020
Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing
Michele Moschetta , Yawara Kawano , Antonio Sacco , Angelo Belotti
Current Osteoporosis Reports 15 ( 5) 499 -506
12
2017
Angiogenesis and anti-angiogenic treatment in prostate cancer: mechanisms of action and molecular targets
Evangelia Ioannidou , Michele Moschetta , Sidrah Shah , Jack Steven Parker
International Journal of Molecular Sciences 22 ( 18) 9926
24
2021